| Schedule II.—Valuation and Qualifying Accounts and Reserves ORIX Corporation and Subsidiaries |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
| |
|
Year Ended March 31, 2024 |
|
| Description |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Restructuring cost: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Closed office lease obligations |
|
¥ |
0 |
|
|
¥ |
0 |
|
|
¥ |
23 |
|
|
¥ |
0 |
|
|
¥ |
0 |
|
|
¥ |
23 |
|
| Severance and other benefits to terminated employees |
|
¥ |
480 |
|
|
¥ |
0 |
|
|
¥ |
122 |
|
|
¥ |
(480 |
) |
|
¥ |
0 |
|
|
¥ |
122 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Total |
|
¥ |
480 |
|
|
¥ |
0 |
|
|
¥ |
145 |
|
|
¥ |
(480 |
) |
|
¥ |
0 |
|
|
¥ |
145 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
| |
|
Year Ended March 31, 2025 |
|
| Description |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Restructuring cost: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Closed office lease obligations |
|
¥ |
23 |
|
|
¥ |
0 |
|
|
¥ |
49 |
|
|
¥ |
(23 |
) |
|
¥ |
0 |
|
|
¥ |
49 |
|
| Severance and other benefits to terminated employees |
|
¥ |
122 |
|
|
¥ |
0 |
|
|
¥ |
0 |
|
|
¥ |
(122 |
) |
|
¥ |
0 |
|
|
¥ |
0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Total |
|
¥ |
145 |
|
|
¥ |
0 |
|
|
¥ |
49 |
|
|
¥ |
(145 |
) |
|
¥ |
0 |
|
|
¥ |
49 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
| |
|
Year Ended March 31, 2026 |
|
| Description |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Restructuring cost: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Closed office lease obligations |
|
¥ |
49 |
|
|
¥ |
0 |
|
|
¥ |
0 |
|
|
¥ |
(38 |
) |
|
¥ |
0 |
|
|
¥ |
11 |
|
| Severance and other benefits to terminated employees |
|
¥ |
0 |
|
|
¥ |
0 |
|
|
¥ |
323 |
|
|
¥ |
0 |
|
|
¥ |
0 |
|
|
¥ |
323 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Total |
|
¥ |
49 |
|
|
¥ |
0 |
|
|
¥ |
323 |
|
|
¥ |
(38 |
) |
|
¥ |
0 |
|
|
¥ |
334 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
| Description |
|
Balance at
beginning
of period |
|
|
|
|
|
Charged to
costs and
expenses |
|
|
|
|
|
|
|
|
|
|
| Deferred tax assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Valuation allowance |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Year ended March 31, 2024 |
|
¥ |
37,287 |
|
|
¥ |
0 |
|
|
¥ |
12,714 |
|
|
¥ |
(12,233 |
) |
|
¥ |
1,278 |
|
|
¥ |
39,046 |
|
| Year ended March 31, 2025 |
|
¥ |
39,046 |
|
|
¥ |
0 |
|
|
¥ |
8,481 |
|
|
¥ |
(15,572 |
) |
|
¥ |
3,890 |
|
|
¥ |
35,845 |
|
| Year ended March 31, 2026 |
|
¥ |
35,845 |
|
|
¥ |
37 |
|
|
¥ |
11,873 |
|
|
¥ |
(3,369 |
) |
|
¥ |
(124 |
) |
|
¥ |
44,262 |
|
| *1 |
The amount of deduction includes benefits recognized in income tax expense, expiration of loss carryforwards and sales of subsidiaries. The amounts of benefits recognized in earnings due to the utilization of net operation loss carry forwards were ¥3,660 million in fiscal 2024, ¥3,380 million in fiscal 2025 and ¥1,877 million in fiscal 2026. The remaining amounts of benefits recognized in earnings were ¥3,613 million in fiscal 2024, ¥3,128 million in fiscal 2025 and ¥812 million in fiscal 2026. |
| *2 |
The amount of other includes, among others, translation adjustment and the effect of changes in statutory income tax rates. |
|